salvin has been researched along with Brain Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lan, Q; Mao, J; Shao, N; Wang, R; Xue, L; Zhi, F | 1 |
| Aiello, C; Bellese, G; Bisio, A; Castagnola, P; Cortese, K; Daga, A; Monticone, M; Stefanelli, A; Tavella, S | 1 |
2 other study(ies) available for salvin and Brain Neoplasms
| Article | Year |
|---|---|
Carnosic acid potentiates the anticancer effect of temozolomide by inducing apoptosis and autophagy in glioma.
Topics: Abietanes; Antineoplastic Agents, Alkylating; Apoptosis; Autophagy; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Synergism; Glioma; Humans; Temozolomide | 2019 |
Carnosic acid induces proteasomal degradation of Cyclin B1, RB and SOX2 along with cell growth arrest and apoptosis in GBM cells.
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Apoptosis; Astrocytes; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin B1; DNA, Neoplasm; Dose-Response Relationship, Drug; G2 Phase; Glioblastoma; Humans; Proteasome Endopeptidase Complex; Retinoblastoma Protein; SOXB1 Transcription Factors | 2016 |